In conclusion, our meta-analysis demonstrated that overexpression of MCM3AP-AS1 in cancers was significantly associated with poor survival and CFS. The gene discussed is MCM3AP; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.